person · Reporting owner
Douglas Robert Andrew
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 15,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 15,000 · Balance 15,000 F1: These options were granted on January 21, 2026, and will vest on January 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and will vest on January 1, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date January 02, 2024 · Filed January 03, 2024
Section 16 reporting ended · disclosed 2024-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 11,080 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,080 F1: Mr. Douglas is no longer subject to reporting under his new role. |
| ResMed Common StockSEC Table I · non-derivative | IndirectDouglas Family Trust | 253,295 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 253,295 |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Douglas is no longer subject to reporting under his new role.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2019 Filed Mar 19, 2019 21:31 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $100.90 | $333,676.30 |
DisclosureSEC source: 0001127602-19-012302 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,297 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 21:31 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001127602-19-012302 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 18:30 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 6,876 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001567619-19-005560 · doc1.xml · derivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Commmon Stock · 6,876 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 18:30 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 6,876 | $43.63 | $299,999.88 |
DisclosureSEC source: 0001567619-19-005560 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 23:49 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001567619-19-004935 · doc1.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,451 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 23:49 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,006 | $99.95 | $100,549.70 |
DisclosureSEC source: 0001567619-19-004935 · doc1.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 154,326 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 23:49 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $99.95 | $330,534.65 |
DisclosureSEC source: 0001567619-19-004935 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,421 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 23:49 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001567619-19-004935 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001567619-19-001242 · doc1.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,758 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:25 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 881 | $114.18 | $100,592.58 |
DisclosureSEC source: 0001567619-19-001242 · doc1.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 155,332 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:25 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $114.18 | $377,593.26 |
DisclosureSEC source: 0001567619-19-001242 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,421 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 21:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001567619-19-001242 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 00:15 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001567619-18-008313 · doc1.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,065 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 00:15 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 886 | $112.56 | $99,728.16 |
DisclosureSEC source: 0001567619-18-008313 · doc1.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 108,336 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 00:15 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $112.56 | $372,235.92 |
DisclosureSEC source: 0001567619-18-008313 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,298 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 00:15 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001567619-18-008313 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 22:55 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 38,465 | $104.18 | $4,007,283.70 |
DisclosureSEC source: 0001567619-18-006943 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,298 F2 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015. Read SEC document |
| November 21, 2018 Filed Nov 26, 2018 22:55 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 68,958 | $104.18 | $7,184,044.44 |
DisclosureSEC source: 0001567619-18-006943 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,763 F1 · shares: Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on November 21, 2018, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 20:24 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 3,307 | $0.00 Strike: $43.63 | $0.00 |
DisclosureSEC source: 0001567619-18-006626 · doc1.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,372 Underlying: ResMed Commmon Stock · 3,307 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 20:24 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 984 | $101.44 | $99,816.96 |
DisclosureSEC source: 0001567619-18-006626 · doc1.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 109,222 Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 20:24 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 3,307 | $101.44 | $335,462.08 |
DisclosureSEC source: 0001567619-18-006626 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,805 Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 20:24 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 3,307 | $43.63 | $144,284.41 |
DisclosureSEC source: 0001567619-18-006626 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2018 Filed Nov 17, 2018 01:17 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 102,975 | $0.00 Strike: $101.64 | $0.00 |
DisclosureSEC source: 0001567619-18-006570 · doc1.xml · derivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,975 Underlying: ResMed Commmon Stock · 102,975 shares Expires 2025-11-14 F1 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2018, 2019 and 2020. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 02:39 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 5,994 | $106.94 | $640,998.36 |
DisclosureSEC source: 0001567619-18-005911 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,805 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. F3 · balance_after: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 09, 2018 Filed Nov 14, 2018 02:39 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 2,018 | $106.94 | $215,804.92 |
DisclosureSEC source: 0001567619-18-005911 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,799 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017. F2 · balance_after: Includes 128.63 shares of ResMed stock purchased on October 31, 2018, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 21:50 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 7,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-004792 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,688 F1 · shares: Represents performance-based restricted stock units granted on November 16, 2017. The shares were earned on October 29, 2018, when the compensation committee certified that the performance metrics were met. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 23:52 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 13,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-18-001327 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,306 F1 · shares: Represents performance-based restricted stock units initially granted on November 16, 2017. The shares were earned on August 15, 2018, when the compensation committee certified that the performance metrics were met. Read SEC document |
| December 05, 2017 Filed Dec 6, 2017 17:31 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 1,184 | $84.46 | $100,000.64 |
DisclosureSEC source: 0001140361-17-045162 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 110,063 F1 · shares: Represents a gift of shares to the Douglas Family Fund-Giving charitable account. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares. F2 · price: The price reported above represents the average of the high and low trading price on the day of the transaction. F3 · balance_after: Includes transfer of 19,879 shares between the direct holdings and the Douglas Family Trust indirect holdings on 11/29/2017. Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 23:26 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 9,513 | $84.63 | $805,085.19 |
DisclosureSEC source: 0001140361-17-044014 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,507 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014. Read SEC document |
| November 27, 2017 Filed Nov 28, 2017 23:26 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 18,231 | $84.63 | $1,542,889.53 |
DisclosureSEC source: 0001140361-17-044014 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,020 F1 · kind: Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted November 19, 2014, with a three-year performance period. The shares were earned and vested November 27, 2017, when the ResMed compensation committee certified performance. F2 · shares: Shares earned based on performance at 57% of the target award. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 18:55 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 68,017 | $0.00 Strike: $84.98 | $0.00 |
DisclosureSEC source: 0001140361-17-043346 · doc1.xml · derivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,017 Underlying: ResMed Commmon Stock · 68,017 shares Expires 2024-11-19 F1 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2018, 2019 and 2020. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 20:51 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 6,309 | $83.06 | $524,025.54 |
DisclosureSEC source: 0001140361-17-042704 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,789 F3 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 20:51 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 5,680 | $83.06 | $471,780.80 |
DisclosureSEC source: 0001140361-17-042704 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,098 F1 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014. F2 · balance_after: Includes 177 shares of ResMed stock purchased on October 31, 2017, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| October 10, 2017 Filed Oct 12, 2017 19:40 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 9,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-038520 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,600 F2 · shares: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on October 10, 2017, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| October 10, 2017 Filed Oct 12, 2017 19:40 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 8,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-038520 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,769 F1 · shares: Represents performance-based restricted stock units granted on November 19, 2015. The shares were earned on October 10, 2017, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 15:16 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 36,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-032785 · doc1.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,149 F1 · shares: Represents performance-based restricted stock units initially granted on November 16, 2016. The shares were earned on August 17, 2017, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 17:57 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 4,082 | $59.85 | $244,307.70 |
DisclosureSEC source: 0001140361-16-086731 · doc1.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,864 F4 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014 Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 17:57 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 3,576 | $59.85 | $214,023.60 |
DisclosureSEC source: 0001140361-16-086731 · doc1.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO ResMed Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,946 F2 · shares: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/13/2013. F3 · balance_after: Includes 218 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.